FDA cited Pingdingshan Tianjing Plant Albumen, a Chinese maker of ready-to-eat soy protein isolate, for insanitary conditions and unsupported test results on certificates.
What happened
FDA inspected the facility in Henan, China from August 15 to 17, 2023. Investigators found live insects in the packaging and spray dryer rooms, a gap under the packaging room doors, powder residue on food-contact surfaces after documented cleaning, and no preventive control for recontamination with environmental pathogens such as Salmonella. FDA also found the firm sent U.S. customers certificates of analysis with Salmonella and E. coli results that were not backed by actual testing data, and that testing was done only after the batches shipped.
What FDA found
The hazard analysis did not treat recontamination of the ready-to-eat soy protein isolate with environmental pathogens like Salmonella as a hazard needing a preventive control.
21 CFR 117.130(a)(1)After cleaning was documented, visible soy protein powder remained on food-contact surfaces such as the hand scoop, filling spout and air removal probes, and the only sanitizing step for packaging equipment was turning on a ceiling UV light.
21 CFR 117.135(c)(3)The environmental monitoring program had no records that swabs were ever tested for Salmonella, and the written procedure did not name the test organism, method, laboratory, or corrective actions for positive results.
21 CFR 117.165(b)(3) and 117.150(a)(2)Live insects were found in the post-heat-treatment packaging room and in the adjacent spray dryer room, and there was a gap at the bottom of the packaging room doors.
21 CFR 117.35(c)The ground outside the soy packaging room was overgrown with weeds and used to store scrap metal and old equipment, which can attract and shelter pests.
21 CFR 117.20(a)(1)Certificates of analysis sent to U.S. customers showed Salmonella and E. coli results that were not supported by original testing data; the values were created to meet customer specifications.
21 CFR 117.305
What FDA wants
FDA asks the company to respond in writing within 15 working days describing the specific corrections taken or planned, with documentation, and a timetable if all corrections cannot be finished within that time.
Who should pay attention
- U.S. importers and brands that buy ready-to-eat soy protein isolate from this plant
- companies that rely on supplier certificates of analysis for pathogen results
- quality and food safety teams sourcing protein ingredients from China
This is a summary. Read the original letter on fda.gov.